幹細胞臍帯血の世界市場（～2026年）

• 英文タイトル：Global Stem Cell Umbilical Cord Blood Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04732 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は幹細胞臍帯血のグローバル市場について調査・分析したレポートです。種類別（公的臍帯血バンク、私的臍帯血バンク）市場規模、用途別（がん・腫瘍疾患、慢性白血病、骨髄異形成症候群、血液疾患、ベータサラセミア、鎌状赤血球症、ウィスコット・アルドリッチ、ハーラー症候群、サンフィリッポ症候群）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別幹細胞臍帯血の競争状況、市場シェア ・世界の幹細胞臍帯血市場：種類別市場規模 2015年-2020年（公的臍帯血バンク、私的臍帯血バンク） ・世界の幹細胞臍帯血市場：種類別市場規模予測 2021年-2026年（公的臍帯血バンク、私的臍帯血バンク） ・世界の幹細胞臍帯血市場：用途別市場規模 2015年-2020年（がん・腫瘍疾患、慢性白血病、骨髄異形成症候群、血液疾患、ベータサラセミア、鎌状赤血球症、ウィスコット・アルドリッチ、ハーラー症候群、サンフィリッポ症候群） ・世界の幹細胞臍帯血市場：用途別市場規模予測 2021年-2026年（がん・腫瘍疾患、慢性白血病、骨髄異形成症候群、血液疾患、ベータサラセミア、鎌状赤血球症、ウィスコット・アルドリッチ、ハーラー症候群、サンフィリッポ症候群） ・北米の幹細胞臍帯血市場分析：米国、カナダ ・ヨーロッパの幹細胞臍帯血市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの幹細胞臍帯血市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の幹細胞臍帯血市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの幹細胞臍帯血市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Advanced Cell Technology、California Stem Cell、Cytori Therapeutics、Mesoblast Limited、Opexa Therapeutics、Athersys、Geron Corporation、Neostem ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Umbilical cord blood (UCB) stem cells have gained much significance in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood that remains in the attached umbilical cord and placenta after childbirth. Stem cells that UCB contains are considered unique in their applicability in treating several life-threatening diseases. UCB stem cells are also used to treat genetic and hematopoietic disorders.
Increase in the prevalence rate of chronic diseases such as cancer, diabetes, blood disease, immune disease, metabolic disease etc. Has increased the need of cost effective and efficient way of treatment. However, cord blood stem cells have the potential to treat these chronic diseases effectively. These stem cells have special property of higher cell count in lower blood volume. Collection of these stem cells is much easier than other stem cells and could be stored in specialized preservation facilities called as Cord Blood Stem Cell Banks.

Market Analysis and Insights: Global Stem Cell Umbilical Cord Blood Market
The global Stem Cell Umbilical Cord Blood market size is projected to reach US$ 19610 million by 2026, from US$ 14560 million in 2020, at a CAGR of 31.0%% during 2021-2026.

Global Stem Cell Umbilical Cord Blood Scope and Market Size
Stem Cell Umbilical Cord Blood market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Stem Cell Umbilical Cord Blood market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics
Athersys
Geron Corporation
Neostem

Market segment by Type, the product can be split into
Public Cord Blood Banks
Private Cord Blood Banks
Market segment by Application, split into
Cancer/ Oncology Diseases
Chronic Leukemia
Myelodysplastic Syndrome
Blood Diseases
Beta Thalassemia
Sickle Cell Disease
Wiskott-Aldrich
Hurler Syndrome
Sanfilippo Syndrome

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Stem Cell Umbilical Cord Blood Revenue
1.4 Market by Type
1.4.1 Global Stem Cell Umbilical Cord Blood Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Public Cord Blood Banks
1.4.3 Private Cord Blood Banks
1.5 Market by Application
1.5.1 Global Stem Cell Umbilical Cord Blood Market Share by Application: 2020 VS 2026
1.5.2 Cancer/ Oncology Diseases
1.5.3 Chronic Leukemia
1.5.4 Myelodysplastic Syndrome
1.5.5 Blood Diseases
1.5.6 Beta Thalassemia
1.5.7 Sickle Cell Disease
1.5.8 Wiskott-Aldrich
1.5.9 Hurler Syndrome
1.5.10 Sanfilippo Syndrome
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Stem Cell Umbilical Cord Blood Market Perspective (2015-2026)
2.2 Global Stem Cell Umbilical Cord Blood Growth Trends by Regions
2.2.1 Stem Cell Umbilical Cord Blood Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Stem Cell Umbilical Cord Blood Historic Market Share by Regions (2015-2020)
2.2.3 Stem Cell Umbilical Cord Blood Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Stem Cell Umbilical Cord Blood Market Growth Strategy
2.3.6 Primary Interviews with Key Stem Cell Umbilical Cord Blood Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Umbilical Cord Blood Players by Market Size
3.1.1 Global Top Stem Cell Umbilical Cord Blood Players by Revenue (2015-2020)
3.1.2 Global Stem Cell Umbilical Cord Blood Revenue Market Share by Players (2015-2020)
3.1.3 Global Stem Cell Umbilical Cord Blood Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Stem Cell Umbilical Cord Blood Market Concentration Ratio
3.2.1 Global Stem Cell Umbilical Cord Blood Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Stem Cell Umbilical Cord Blood Revenue in 2019
3.3 Stem Cell Umbilical Cord Blood Key Players Head office and Area Served
3.4 Key Players Stem Cell Umbilical Cord Blood Product Solution and Service
3.5 Date of Enter into Stem Cell Umbilical Cord Blood Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Stem Cell Umbilical Cord Blood Historic Market Size by Type (2015-2020)
4.2 Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Stem Cell Umbilical Cord Blood Market Size by Application (2015-2020)
5.2 Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Stem Cell Umbilical Cord Blood Market Size (2015-2020)
6.2 Stem Cell Umbilical Cord Blood Key Players in North America (2019-2020)
6.3 North America Stem Cell Umbilical Cord Blood Market Size by Type (2015-2020)
6.4 North America Stem Cell Umbilical Cord Blood Market Size by Application (2015-2020)

7 Europe
7.1 Europe Stem Cell Umbilical Cord Blood Market Size (2015-2020)
7.2 Stem Cell Umbilical Cord Blood Key Players in Europe (2019-2020)
7.3 Europe Stem Cell Umbilical Cord Blood Market Size by Type (2015-2020)
7.4 Europe Stem Cell Umbilical Cord Blood Market Size by Application (2015-2020)

8 China
8.1 China Stem Cell Umbilical Cord Blood Market Size (2015-2020)
8.2 Stem Cell Umbilical Cord Blood Key Players in China (2019-2020)
8.3 China Stem Cell Umbilical Cord Blood Market Size by Type (2015-2020)
8.4 China Stem Cell Umbilical Cord Blood Market Size by Application (2015-2020)

9 Japan
9.1 Japan Stem Cell Umbilical Cord Blood Market Size (2015-2020)
9.2 Stem Cell Umbilical Cord Blood Key Players in Japan (2019-2020)
9.3 Japan Stem Cell Umbilical Cord Blood Market Size by Type (2015-2020)
9.4 Japan Stem Cell Umbilical Cord Blood Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Stem Cell Umbilical Cord Blood Market Size (2015-2020)
10.2 Stem Cell Umbilical Cord Blood Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Stem Cell Umbilical Cord Blood Market Size by Type (2015-2020)
10.4 Southeast Asia Stem Cell Umbilical Cord Blood Market Size by Application (2015-2020)

11 India
11.1 India Stem Cell Umbilical Cord Blood Market Size (2015-2020)
11.2 Stem Cell Umbilical Cord Blood Key Players in India (2019-2020)
11.3 India Stem Cell Umbilical Cord Blood Market Size by Type (2015-2020)
11.4 India Stem Cell Umbilical Cord Blood Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Stem Cell Umbilical Cord Blood Market Size (2015-2020)
12.2 Stem Cell Umbilical Cord Blood Key Players in Central & South America (2019-2020)
12.3 Central & South America Stem Cell Umbilical Cord Blood Market Size by Type (2015-2020)
12.4 Central & South America Stem Cell Umbilical Cord Blood Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Advanced Cell Technology
13.1.1 Advanced Cell Technology Company Details
13.1.2 Advanced Cell Technology Business Overview
13.1.3 Advanced Cell Technology Stem Cell Umbilical Cord Blood Introduction
13.1.4 Advanced Cell Technology Revenue in Stem Cell Umbilical Cord Blood Business (2015-2020))
13.1.5 Advanced Cell Technology Recent Development
13.2 California Stem Cell
13.2.1 California Stem Cell Company Details
13.2.2 California Stem Cell Business Overview
13.2.3 California Stem Cell Stem Cell Umbilical Cord Blood Introduction
13.2.4 California Stem Cell Revenue in Stem Cell Umbilical Cord Blood Business (2015-2020)
13.2.5 California Stem Cell Recent Development
13.3 Cytori Therapeutics
13.3.1 Cytori Therapeutics Company Details
13.3.2 Cytori Therapeutics Business Overview
13.3.3 Cytori Therapeutics Stem Cell Umbilical Cord Blood Introduction
13.3.4 Cytori Therapeutics Revenue in Stem Cell Umbilical Cord Blood Business (2015-2020)
13.3.5 Cytori Therapeutics Recent Development
13.4 Mesoblast Limited
13.4.1 Mesoblast Limited Company Details
13.4.2 Mesoblast Limited Business Overview
13.4.3 Mesoblast Limited Stem Cell Umbilical Cord Blood Introduction
13.4.4 Mesoblast Limited Revenue in Stem Cell Umbilical Cord Blood Business (2015-2020)
13.4.5 Mesoblast Limited Recent Development
13.5 Opexa Therapeutics
13.5.1 Opexa Therapeutics Company Details
13.5.2 Opexa Therapeutics Business Overview
13.5.3 Opexa Therapeutics Stem Cell Umbilical Cord Blood Introduction
13.5.4 Opexa Therapeutics Revenue in Stem Cell Umbilical Cord Blood Business (2015-2020)
13.5.5 Opexa Therapeutics Recent Development
13.6 Athersys
13.6.1 Athersys Company Details
13.6.2 Athersys Business Overview
13.6.3 Athersys Stem Cell Umbilical Cord Blood Introduction
13.6.4 Athersys Revenue in Stem Cell Umbilical Cord Blood Business (2015-2020)
13.6.5 Athersys Recent Development
13.7 Geron Corporation
13.7.1 Geron Corporation Company Details
13.7.2 Geron Corporation Business Overview
13.7.3 Geron Corporation Stem Cell Umbilical Cord Blood Introduction
13.7.4 Geron Corporation Revenue in Stem Cell Umbilical Cord Blood Business (2015-2020)
13.7.5 Geron Corporation Recent Development
13.8 Neostem
13.8.1 Neostem Company Details
13.8.2 Neostem Business Overview
13.8.3 Neostem Stem Cell Umbilical Cord Blood Introduction
13.8.4 Neostem Revenue in Stem Cell Umbilical Cord Blood Business (2015-2020)
13.8.5 Neostem Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Stem Cell Umbilical Cord Blood Key Market Segments
Table 2. Key Players Covered: Ranking by Stem Cell Umbilical Cord Blood Revenue
Table 3. Ranking of Global Top Stem Cell Umbilical Cord Blood Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Stem Cell Umbilical Cord Blood Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Public Cord Blood Banks
Table 6. Key Players of Private Cord Blood Banks
Table 7. Global Stem Cell Umbilical Cord Blood Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Stem Cell Umbilical Cord Blood Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Stem Cell Umbilical Cord Blood Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Stem Cell Umbilical Cord Blood Market Share by Regions (2015-2020)
Table 11. Global Stem Cell Umbilical Cord Blood Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Stem Cell Umbilical Cord Blood Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Stem Cell Umbilical Cord Blood Market Growth Strategy
Table 17. Main Points Interviewed from Key Stem Cell Umbilical Cord Blood Players
Table 18. Global Stem Cell Umbilical Cord Blood Revenue by Players (2015-2020) (Million US$)
Table 19. Global Stem Cell Umbilical Cord Blood Market Share by Players (2015-2020)
Table 20. Global Top Stem Cell Umbilical Cord Blood Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Umbilical Cord Blood as of 2019)
Table 21. Global Stem Cell Umbilical Cord Blood by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Stem Cell Umbilical Cord Blood Product Solution and Service
Table 24. Date of Enter into Stem Cell Umbilical Cord Blood Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Stem Cell Umbilical Cord Blood Market Size by Type (2015-2020) (Million US$)
Table 27. Global Stem Cell Umbilical Cord Blood Market Size Share by Type (2015-2020)
Table 28. Global Stem Cell Umbilical Cord Blood Revenue Market Share by Type (2021-2026)
Table 29. Global Stem Cell Umbilical Cord Blood Market Size Share by Application (2015-2020)
Table 30. Global Stem Cell Umbilical Cord Blood Market Size by Application (2015-2020) (Million US$)
Table 31. Global Stem Cell Umbilical Cord Blood Market Size Share by Application (2021-2026)
Table 32. North America Key Players Stem Cell Umbilical Cord Blood Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Stem Cell Umbilical Cord Blood Market Share (2019-2020)
Table 34. North America Stem Cell Umbilical Cord Blood Market Size by Type (2015-2020) (Million US$)
Table 35. North America Stem Cell Umbilical Cord Blood Market Share by Type (2015-2020)
Table 36. North America Stem Cell Umbilical Cord Blood Market Size by Application (2015-2020) (Million US$)
Table 37. North America Stem Cell Umbilical Cord Blood Market Share by Application (2015-2020)
Table 38. Europe Key Players Stem Cell Umbilical Cord Blood Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Stem Cell Umbilical Cord Blood Market Share (2019-2020)
Table 40. Europe Stem Cell Umbilical Cord Blood Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Stem Cell Umbilical Cord Blood Market Share by Type (2015-2020)
Table 42. Europe Stem Cell Umbilical Cord Blood Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Stem Cell Umbilical Cord Blood Market Share by Application (2015-2020)
Table 44. China Key Players Stem Cell Umbilical Cord Blood Revenue (2019-2020) (Million US$)
Table 45. China Key Players Stem Cell Umbilical Cord Blood Market Share (2019-2020)
Table 46. China Stem Cell Umbilical Cord Blood Market Size by Type (2015-2020) (Million US$)
Table 47. China Stem Cell Umbilical Cord Blood Market Share by Type (2015-2020)
Table 48. China Stem Cell Umbilical Cord Blood Market Size by Application (2015-2020) (Million US$)
Table 49. China Stem Cell Umbilical Cord Blood Market Share by Application (2015-2020)
Table 50. Japan Key Players Stem Cell Umbilical Cord Blood Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Stem Cell Umbilical Cord Blood Market Share (2019-2020)
Table 52. Japan Stem Cell Umbilical Cord Blood Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Stem Cell Umbilical Cord Blood Market Share by Type (2015-2020)
Table 54. Japan Stem Cell Umbilical Cord Blood Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Stem Cell Umbilical Cord Blood Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Stem Cell Umbilical Cord Blood Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Stem Cell Umbilical Cord Blood Market Share (2019-2020)
Table 58. Southeast Asia Stem Cell Umbilical Cord Blood Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Stem Cell Umbilical Cord Blood Market Share by Type (2015-2020)
Table 60. Southeast Asia Stem Cell Umbilical Cord Blood Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Stem Cell Umbilical Cord Blood Market Share by Application (2015-2020)
Table 62. India Key Players Stem Cell Umbilical Cord Blood Revenue (2019-2020) (Million US$)
Table 63. India Key Players Stem Cell Umbilical Cord Blood Market Share (2019-2020)
Table 64. India Stem Cell Umbilical Cord Blood Market Size by Type (2015-2020) (Million US$)
Table 65. India Stem Cell Umbilical Cord Blood Market Share by Type (2015-2020)
Table 66. India Stem Cell Umbilical Cord Blood Market Size by Application (2015-2020) (Million US$)
Table 67. India Stem Cell Umbilical Cord Blood Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Stem Cell Umbilical Cord Blood Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Stem Cell Umbilical Cord Blood Market Share (2019-2020)
Table 70. Central & South America Stem Cell Umbilical Cord Blood Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Stem Cell Umbilical Cord Blood Market Share by Type (2015-2020)
Table 72. Central & South America Stem Cell Umbilical Cord Blood Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Stem Cell Umbilical Cord Blood Market Share by Application (2015-2020)
Table 74. Advanced Cell Technology Company Details
Table 75. Advanced Cell Technology Business Overview
Table 76. Advanced Cell Technology Product
Table 77. Advanced Cell Technology Revenue in Stem Cell Umbilical Cord Blood Business (2015-2020) (Million US$)
Table 78. Advanced Cell Technology Recent Development
Table 79. California Stem Cell Company Details
Table 80. California Stem Cell Business Overview
Table 81. California Stem Cell Product
Table 82. California Stem Cell Revenue in Stem Cell Umbilical Cord Blood Business (2015-2020) (Million US$)
Table 83. California Stem Cell Recent Development
Table 84. Cytori Therapeutics Company Details
Table 85. Cytori Therapeutics Business Overview
Table 86. Cytori Therapeutics Product
Table 87. Cytori Therapeutics Revenue in Stem Cell Umbilical Cord Blood Business (2015-2020) (Million US$)
Table 88. Cytori Therapeutics Recent Development
Table 89. Mesoblast Limited Company Details
Table 90. Mesoblast Limited Business Overview
Table 91. Mesoblast Limited Product
Table 92. Mesoblast Limited Revenue in Stem Cell Umbilical Cord Blood Business (2015-2020) (Million US$)
Table 93. Mesoblast Limited Recent Development
Table 94. Opexa Therapeutics Company Details
Table 95. Opexa Therapeutics Business Overview
Table 96. Opexa Therapeutics Product
Table 97. Opexa Therapeutics Revenue in Stem Cell Umbilical Cord Blood Business (2015-2020) (Million US$)
Table 98. Opexa Therapeutics Recent Development
Table 99. Athersys Company Details
Table 100. Athersys Business Overview
Table 101. Athersys Product
Table 102. Athersys Revenue in Stem Cell Umbilical Cord Blood Business (2015-2020) (Million US$)
Table 103. Athersys Recent Development
Table 104. Geron Corporation Company Details
Table 105. Geron Corporation Business Overview
Table 106. Geron Corporation Product
Table 107. Geron Corporation Revenue in Stem Cell Umbilical Cord Blood Business (2015-2020) (Million US$)
Table 108. Geron Corporation Recent Development
Table 109. Neostem Business Overview
Table 110. Neostem Product
Table 111. Neostem Company Details
Table 112. Neostem Revenue in Stem Cell Umbilical Cord Blood Business (2015-2020) (Million US$)
Table 113. Neostem Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stem Cell Umbilical Cord Blood Market Share by Type: 2020 VS 2026
Figure 2. Public Cord Blood Banks Features
Figure 3. Private Cord Blood Banks Features
Figure 4. Global Stem Cell Umbilical Cord Blood Market Share by Application: 2020 VS 2026
Figure 5. Cancer/ Oncology Diseases Case Studies
Figure 6. Chronic Leukemia Case Studies
Figure 7. Myelodysplastic Syndrome Case Studies
Figure 8. Blood Diseases Case Studies
Figure 9. Beta Thalassemia Case Studies
Figure 10. Sickle Cell Disease Case Studies
Figure 11. Wiskott-Aldrich Case Studies
Figure 12. Hurler Syndrome Case Studies
Figure 13. Sanfilippo Syndrome Case Studies
Figure 14. Stem Cell Umbilical Cord Blood Report Years Considered
Figure 15. Global Stem Cell Umbilical Cord Blood Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Stem Cell Umbilical Cord Blood Market Share by Regions: 2020 VS 2026
Figure 17. Global Stem Cell Umbilical Cord Blood Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Stem Cell Umbilical Cord Blood Market Share by Players in 2019
Figure 20. Global Top Stem Cell Umbilical Cord Blood Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stem Cell Umbilical Cord Blood as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Stem Cell Umbilical Cord Blood Revenue in 2019
Figure 22. North America Stem Cell Umbilical Cord Blood Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Stem Cell Umbilical Cord Blood Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Stem Cell Umbilical Cord Blood Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Stem Cell Umbilical Cord Blood Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Stem Cell Umbilical Cord Blood Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Stem Cell Umbilical Cord Blood Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Stem Cell Umbilical Cord Blood Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed

---